PureTech Founded Entity Seaport Therapeutics Presents Additional Pharmacokinetic Data from Phase 1 Clinical Trial of GlyphAgo™ at the 39th European College of Neuropsychopharmacology (ECNP) Congress
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| (NASDAQ: SPTX) | Delayed: 20.01 +0.41 (2.09%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $19.60 | 52 Week High | $ | |||
| Open | $19.68 | 52 Week Low | $ | |||
| Day High | $21.07 | P/E | N/A | |||
| Day Low | $19.13 | EPS | $ | |||
| Volume | 527,902 | |||||
